Chemical and Mechanical Synergistic Modulation for Engineered Tumor Cells Enables High‐Performance Biomimetic Detection of Circulating Tumor Cells
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Lanlan Jia und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Biomimetics, Biomimetic Materials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Although the idea of employing cell membrane biomimetic technologies for detecting circulating tumor cells (CTCs) promises paradigm‐shifting advances in cancer diagnostics, its wide application is restricted by CTCs phenotypic variations. Current improvements primarily focus on optimizing biomimetic coatings to enhance capture efficiency, but there remains a significant gap between existing strategies and the practical demands of CTCs detection. Herein, a novel method considering the perspective of tumor cell modification was proposed, which involved concurrently modulating cellular chemical and mechanical properties. Specifically, the strategy employed metabolic glycoengineering to selectively remold tumor cells, thereby introducing artificial receptors into the tumor cell membrane. Additionally, Cytochalasin D, a drug that can interfere with the cytoskeleton, was used to alter the mechanical properties of the cell membrane, softening it and thereby significantly enhancing the contact area and adhesion ability between target cells and the substrate surface. To cope with the complex application environment, a visual biomimetic detection system was developed, leveraging the homologous targeting properties of the tumor cell biomimetic layer in combination with advanced colorimetric nanoprobes, enabling highly sensitive and specific detection of engineered CTCs. Overall, this approach adeptly circumvents challenges associated with biomarker bias, offering a robust method for non‐invasive cancer diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China.
- Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis, Xi'an, China.
- The Comprehensive Breast Care Center, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China.
ORCID-Profile: Xiaoyu Xie
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Jia, L., Zhu, A., Hu, Q., Li, M., Du, C., Sun, Y., Zhang, T., Chen, Y., Guo, J., & Xie, X. (2026). Chemical and Mechanical Synergistic Modulation for Engineered Tumor Cells Enables High‐Performance Biomimetic Detection of Circulating Tumor Cells. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505535
Vancouver
Jia L, Zhu A, Hu Q, Li M, Du C, Sun Y, et al. Chemical and Mechanical Synergistic Modulation for Engineered Tumor Cells Enables High‐Performance Biomimetic Detection of Circulating Tumor Cells. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505535
BibTeX
@article{Jia2026,
author = {Jia, Lanlan and Zhu, Aihong and Hu, Qi and Li, Min and Du, Chong and Sun, Yihan and Zhang, Tingting and Chen, Yuxin and Guo, Jialin and Xie, Xiaoyu},
title = {Chemical and Mechanical Synergistic Modulation for Engineered Tumor Cells Enables High‐Performance Biomimetic Detection of Circulating Tumor Cells},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505535}
}
EUVIMED